As the corporate venture capital arm of Sanofi, we invest in top-tier biotech and digital health companies that focus on helping patients and transforming the practice of medicine. We invest across all stages of the private company lifecycle, from Seed to Series B and beyond, while leading financings, serving on boards, and taking pride in working alongside portfolio companies to drive long-term value through future financings and IPO.
Our raison d'être
We invest in the innovators behind the miracles of science who are passionate about improving human health. Sanofi Ventures serves as an entry point to the innovation ecosystem for Sanofi, strategically investing in early-stage transformational science and technology, when companies are too early to partner with or acquire.
How We Work
Think of us like institutional venture capitalists with an added bonus: in addition to our investment, we aim to offer our portfolio companies select access to Sanofi’s expertise and capabilities in science, preclinical and clinical development, regulatory, data analytics, manufacturing, market access, and commercialization.
Our goal is to foster strong relationships over time so when our portfolio company is ready to consider a partnership or acquisition, our colleagues on the BD and M&A teams can be a first and last call.
We move quickly, we don’t believe in drawn-out processes, and we always aim to provide thoughtful feedback.
Our Investment Focus
We invest in early-stage biotech and digital health companies of strategic interest to Sanofi.
We seek to accelerate all strategic focus while reaching into novel and emerging areas of science and technology.
Here are some of the areas that we currently are thinking about:
- Rare diseases
- Immunology and inflammation
- Oncology
- Cell and gene therapy
- Vaccines
- Digital health and data science
We can't do it alone - we would love to hear how we can team up to improve human health for people everywhere!